TWI388318B - 具有改良之生物相容性的含有肉毒鹼之腹膜透析溶液 - Google Patents

具有改良之生物相容性的含有肉毒鹼之腹膜透析溶液 Download PDF

Info

Publication number
TWI388318B
TWI388318B TW095105650A TW95105650A TWI388318B TW I388318 B TWI388318 B TW I388318B TW 095105650 A TW095105650 A TW 095105650A TW 95105650 A TW95105650 A TW 95105650A TW I388318 B TWI388318 B TW I388318B
Authority
TW
Taiwan
Prior art keywords
carnitine
acid
peritoneal dialysis
glucose
solution
Prior art date
Application number
TW095105650A
Other languages
English (en)
Chinese (zh)
Other versions
TW200714279A (en
Inventor
阿多伊尼 阿多伊諾
Original Assignee
西格瑪 陶製藥廠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 西格瑪 陶製藥廠 filed Critical 西格瑪 陶製藥廠
Publication of TW200714279A publication Critical patent/TW200714279A/zh
Application granted granted Critical
Publication of TWI388318B publication Critical patent/TWI388318B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW095105650A 2005-03-10 2006-02-20 具有改良之生物相容性的含有肉毒鹼之腹膜透析溶液 TWI388318B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2005000130 2005-03-10

Publications (2)

Publication Number Publication Date
TW200714279A TW200714279A (en) 2007-04-16
TWI388318B true TWI388318B (zh) 2013-03-11

Family

ID=35159907

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095105650A TWI388318B (zh) 2005-03-10 2006-02-20 具有改良之生物相容性的含有肉毒鹼之腹膜透析溶液

Country Status (19)

Country Link
US (1) US20080138443A1 (https=)
EP (1) EP1858504B1 (https=)
JP (2) JP4717110B2 (https=)
KR (1) KR101324920B1 (https=)
AR (1) AR054015A1 (https=)
AT (1) ATE539742T1 (https=)
CA (1) CA2599252C (https=)
CY (1) CY1112794T1 (https=)
DK (1) DK1858504T3 (https=)
ES (1) ES2380168T3 (https=)
HR (1) HRP20120177T1 (https=)
ME (1) ME02948B (https=)
MX (1) MX2007010814A (https=)
PL (1) PL1858504T3 (https=)
PT (1) PT1858504E (https=)
RS (1) RS52237B (https=)
SI (1) SI1858504T1 (https=)
TW (1) TWI388318B (https=)
WO (1) WO2006094900A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2365429B1 (es) * 2010-03-05 2012-09-06 Universidad De Castilla De La Mancha Solucion para dialisis peritoneal
WO2018031922A1 (en) * 2016-08-11 2018-02-15 Sulfilatec, Inc. Medical and nutritional compositions and methods of use
ES2750642A1 (es) * 2018-09-26 2020-03-26 Univ Vigo Composición farmacéutica que comprende proteína amiloide P de suero para tratar la insuficiencia renal aguda o crónica
EP3912656A1 (en) 2020-05-19 2021-11-24 CoreQuest Sagl Peritoneal dialysis solution

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126373A (en) 1987-11-19 1992-06-30 Henri Brunengraber Composition for parenteral and oral nutrition
JPH08131542A (ja) * 1994-11-11 1996-05-28 Baxter Kk 腹膜透析液調製用溶液セット
CA2155910C (en) 1995-08-11 1999-12-14 George Wu Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
GB9714218D0 (en) * 1997-07-04 1997-09-10 Allied Therapeutics Ltd Peritoneal dialysis fluid
EP1009452A4 (en) * 1997-08-07 2004-03-31 Ajay Gupta WATER-SOLUBLE VITAMINS AND DIALYSIS SOLUTION CONTAINING NUTRIENTS
DE19748290B8 (de) 1997-10-31 2009-09-03 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse
JP4638106B2 (ja) 1999-10-11 2011-02-23 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ 医薬的使用のための溶液中における浸透圧剤としての、ｌ−カルニチンおよびそのアルカノイル誘導体の使用
JP2002282354A (ja) 2001-03-27 2002-10-02 Jms Co Ltd 腹膜透析液
GB0108359D0 (en) * 2001-04-03 2001-05-23 Allied Therapeutics Ltd Peritoneal dialysis fluid
ITRM20010337A1 (it) * 2001-06-14 2002-12-16 Sigma Tau Ind Farmaceuti Soluzione per la conservazione e perfuzione di organi in attesa che vengano trapiantati.
FR2840612B1 (fr) * 2002-06-06 2005-05-06 Roquette Freres Polymeres solubles de glucose hautement branches et leur procede d'obtention
JP2004016615A (ja) * 2002-06-19 2004-01-22 Fuso Pharmaceutical Industries Ltd 晶質浸透圧剤及び膠質浸透圧剤を含有する腹膜透析液
US20060046975A1 (en) 2002-12-10 2006-03-02 Ola Carlsson Method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
JP2006075195A (ja) * 2004-09-07 2006-03-23 Jms Co Ltd Ｌカルニチン含有腹膜透析液

Also Published As

Publication number Publication date
SI1858504T1 (sl) 2012-04-30
ATE539742T1 (de) 2012-01-15
MX2007010814A (es) 2007-11-07
KR20070116630A (ko) 2007-12-10
PL1858504T3 (pl) 2012-05-31
CA2599252C (en) 2013-07-30
EP1858504B1 (en) 2012-01-04
JP4717110B2 (ja) 2011-07-06
PT1858504E (pt) 2012-04-10
CY1112794T1 (el) 2016-02-10
TW200714279A (en) 2007-04-16
EP1858504A1 (en) 2007-11-28
ES2380168T3 (es) 2012-05-09
US20080138443A1 (en) 2008-06-12
DK1858504T3 (da) 2012-04-30
JP2010207630A (ja) 2010-09-24
JP2008532601A (ja) 2008-08-21
WO2006094900A1 (en) 2006-09-14
KR101324920B1 (ko) 2013-11-01
JP5366894B2 (ja) 2013-12-11
RS52237B (sr) 2012-10-31
ME02948B (me) 2012-10-31
AR054015A1 (es) 2007-05-30
HRP20120177T1 (hr) 2012-03-31
CA2599252A1 (en) 2006-09-14

Similar Documents

Publication Publication Date Title
US5116868A (en) Effective ophthalmic irrigation solution
JP6130666B2 (ja) １種以上のクレアチン化合物を含んでなる血液透析液及び腹膜透析液
EA013846B1 (ru) Фармацевтическая композиция, содержащая лактат, и ее применение
US20090232908A1 (en) Stable aqueous solution containing sodium pyruvate, and the preparation and use thereof
CA2788865A1 (en) Composition comprising as active ingredient l-carnitine in combination with hydroxykynurenine-0-beta-dl-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation
CN104382891B (zh) 通过施用肌酸化合物的透析患者中的细胞保护
EP0270026A2 (en) Pharmaceutical preparation comprising vitamin B6
TWI388318B (zh) 具有改良之生物相容性的含有肉毒鹼之腹膜透析溶液
EP0562188B1 (en) Composition for tissues to sustain viability and biological functions in surgery and storage
JP3182564B2 (ja) 栄養組成物
EP0355453A2 (en) Use of 3-hydroxybutyric acid as an energy source
RU2226093C1 (ru) Кардиоплегический раствор "инфузол"
Nutting et al. The vasorelaxant effects of acetate: role of adenosine, glycolysis, lyotropism, and pHi and Cai2+
Clode et al. A stage‐dependent effect of ethanol on 9.5‐day rat embryos grown in culture and the role played by the concomitant rise in osmolality
US20030013767A1 (en) Method of treating weight loss using creatine
Bocock et al. Hepatic sulfur amino acid metabolism in rats with chronic renal failure
EP0076841A1 (en) Improved solution for parenteral nutrition
Chen et al. THE EFFICACY OF NON-LACTATE-GENERATING METABOLITES AS SUBSTRATES FOR MAINTAINING DONOR TISSUES1
JPH0733601A (ja) 組織保存用組成物
US20080095865A1 (en) Composition and method for increasing lean muscle mass, decreasing muscle loss, increasing muscle strength and improving athletic performance
JPH02237921A (ja) 酵素不全において使用する組成物
Sutton Causes and prevention of calcium-containing renal calculi
JP2000191401A (ja) 臓器保存剤
AU653586B2 (en) Composition for tissues to sustain viability and biological functions in surgery and storage
Kurtz et al. Chloride as a determinant of salt-sensitivity

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees